Multimodal Deep Learning

AI Model Predicts Late Distant Recurrence Risk in HR-Positive Breast Cancer

HR-positive disease accounts for approximately 70% to 80% of breast cancer diagnoses and carries a risk of recurrence that ...

10d

Caris Life Sciences, ECOG-ACRIN and NRG Oncology Study Demonstrates Multimodal AI Approach to Predict Late Distant Recurrence Risk in HR+ Early Breast Cancer

Caris Life Sciences® (Caris), a leading TechBio company, today announced the publication of a study in Cancer Research Communications demonstrating the ability of a multimodal, multitask deep learning ...

ascopubs.org

Deep-learning model for real-time prediction of recurrence in early-stage non-small cell lung cancer: A multi-modal approach.

Implications of EGFR expression in MAPK dependency and adaptive immunity status of EGFR-mutated lung adenocarcinoma. Baseline RADAR score and optimal threshold of predicting relapse within one year ...

Frontiers

Show inaccessible results

AI Model Predicts Late Distant Recurrence Risk in HR-Positive Breast Cancer

Caris Life Sciences, ECOG-ACRIN and NRG Oncology Study Demonstrates Multimodal AI Approach to Predict Late Distant Recurrence Risk in HR+ Early Breast Cancer

Deep-learning model for real-time prediction of recurrence in early-stage non-small cell lung cancer: A multi-modal approach.

Multimodal and Trustworthy Explainable AI for Next-Generation Diagnosis and Decision-Making in Gastrointestinal Cancers

Contrast-free virtual enhancement: Multi-modal deep learning synthesis of CECT from pCT and MRI.

Advancing Multimodal AI for Integrated Understanding and Generation

Where AI and multimodal learning will go in 2025